Read the Tirzepatide Research Guide. Review the research context and evidence limitations.
TIRZ-GLP3 (20 mg) is supplied for controlled laboratory evaluation of Tirzepatide within Weight Loss / Metabolic Research studies.
- Research material: Tirzepatide
- Listed strength and format: 20 mg Vial
- Research category: Weight Loss / Metabolic Research
TIRZ-GLP3 20 mg and compound selection
This TIRZ-GLP3 listing contains Tirzepatide. Its GIP and GLP-1 receptor research is documented in the LY3298176 compound study. The label should not be confused with RTZ-GLP3 / retatrutide, a different research compound.
The listed 20 mg describes total vial material, not solution concentration. Use the size-comparison links near the price to review other Tirzepatide amounts. Ask SRP about the 20 mg product and batch details. Published findings provide research context, not a guaranteed result for a supplied vial.
For laboratory research only. Not for human or animal use, consumption, administration, diagnosis, treatment, or therapeutic application.
Reviews
There are no reviews yet.